All News
C5orf30 Gene is a Negative Regulator of Tissue Damage in Rheumatoid Arthritis
PNAS has reported the work of an international team of scientists from the University College Dublin and the University of Sheffield, who have studied DNA samples and biopsy samples from joints of over 1,000 rheumatoid arthritis patients in the UK and Ireland and determined the C5orf30 gene to be
Read ArticleDSB: Drug Shortages August 2015
RheumNow is committed to reporting safety issues in our monthly Drug Safety Bulletins. Each month we will update you with reports of new, ongoing and resolved Drug Shortages that will affect the practicing rheumatologist.
Read ArticleIncreased Vascular Mortality in Ankylosing Spondylitis
Haroon et al has analyzed administrative claims data from Ontario, Canada and compared 21473 AS patients with 86606 normal comparators matched for age, sex, and location of residence.
Read ArticleGrowth Hormone Protects Against Osteoporotic Fractures
In a decade-long study of the effects of growth hormone (GH), 80 women with osteoporosis on HRT, between ages of 50-70 yrs were randomized to receive GH 1.0 U or GH 2.5 U recombinant human GH or placebo sc daily during 3 years and compared to an age-matched populatoin sample of (n=120).
Read ArticleHyperuricemia, Death & Kidney Disease
In a recent study published in the Journal of the American Geriatrics SocietyTaiwan investigators examined the Annual Geriatric Health Examination Program database (2006 to 2010) to estimate the all-cause, cardiovascular, and cancer mortality risks associated with serum uric acid le
Read ArticleFemale "Viagra Pill" Controversy - Grandstanding or Equal Rights?
The FDA is under pressure over the recent approval of the "female viagra" pill. On August 18th, the FDA announced its approval for Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
Read ArticleEarly RA and the Chance of DMARD-Free Remission
Early and aggressive treatment of rheumatoid arthritis has become the mantra for most who manage the disease and hope to achieve optimal outcomes - including remission.
Read ArticleBMI at Age 20 Influences Future Risk of Low Back Pain
A nationwide, cross-sectional study of men aged 30–50 years (n=1385) examined the relationship between weight and back pain over time.
Read ArticleFasenmyer Grant to Calabrese and Lederman Will Further the Interface Between Rheumatology and Virology
Two longtime collaborators studying HIV/AIDS at the Cleveland Clinic and Case Western Reserve University have received an $18.5 million grant from the Richard J. Fasenmyer Foundation.
Read ArticleEpidural Steroid Injections Ineffective
A meta-analysis of 30 placebo-controlled trials evaluated epidural corticosteroid injections for radiculopathy, and 8 trials were done for spinal stenosis.
Read ArticleColon Cancer Risk Cut by Aspirin and NSAIDs
A population-based study from Northern Denmark studied the effects of aspirin and NSAIDs on colorectal cancer rates (Citation source http://buff.ly/1KJQ6H3).
Read ArticleSecukinumab Bests Ustekinumab in Psoriasis CLEAR Study
The CLEAR study was a one-year, randomized, double-blind trial compared subcutaneous standard doses of secukinumab (anti-IL17) and ustekinumab (anti-IL12/23) in patients with moderate-severe plaque psoriasis.
Read ArticlePoll: Americans Favor Federal Action on Drug Prices
Most Americans value the prescription products the drug industry produces, but they sure don't like the prices and want the federal government to take action, according to a new survey
Read ArticleAmgen Agrees to $71 Million Settlement over Enbrel & Aranesp Promotion
Based on potentiallly off-label promotion of blockbuster drugs Aranesp and Enbrel, Amgen has agreed to a $71 million settlement with 48 states and the District of Columbia.
Read ArticleSerious Infections are Increasing in Lupus
Tektonidou and coworkers have analyzed hospitalized serious infections (SIE) involving lupus patients over a 15 year period and show that SIE in SLE have increased substantially between 1996 and 2011, and in 2011 are 12 times higher than seen in patients without SLE.
Read ArticlePoor Compliance in SLE Leads to More ER Visits and Hospitalizations
Feldman and coworkers have analyzed US Medicaid claims data from 9,600 hydroxychloroquine and 3,829 new immunosuppressive new users with a diagnosis of SLE.
Read Article"Eye of Newt" Leads Regenerative Therapy in Osteoarthritis
Regeneration of cartilage is the holy grail of osteoarthritis research.
Read ArticleEnthesitis Ultrasound as an Outcome Measure in Spondyloarthritis
Musculoskeletal ultrasound (US) was recently used in a longitudinal study Achilles enthesis of 146 patients with early spondyloarthritis (SpA). Usual measures of SpA activity included BASFI, BASRI-spine, BASDAI and Ankylosing Spondylitis Disease Activity Score (ASDAS).
Read ArticleThalamic Currents Underlie Sleep Problems in Fibromyalgia
Sleep disruption is a core feature of fibromyalgia. People with fibromyalgia exhibit sleep brain wave patterns often disrupted by brain waves that correspond to wakefulness.
Read ArticleCancer Risk Is Both Increased and Decreased in RA
Rheumatoid arthritis patients are often said to have no or a low risk of cancer.
Read Article